查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618261

血液浓缩器:市场洞察·竞争环境·市场预测 (～2030年)

Hemoconcentrators - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

血液浓缩器市场规模预计将从 2023 年的 1,163 万美元增长到 2030 年的 1,404 万美元，预测期内复合年增长率为 3.24%。

由于患有心房颤动等慢性病和冠状动脉疾病（CAD）等心血管疾病的患者数量不断增加、老年人口不断增加、各国政府举措不断增多，血液浓缩器市场正在不断增长，由于越来越专注于提高安全性、可负担性和易用性等因素，预计在预测期内会出现成长。

血液浓缩器：市场动态

根据《世界心臟报告（2023）》的数据，预计2021年全球将有超过5亿人罹患心血管疾病。此外，根据美国心臟协会（2023）的最新数据，预计到 2030 年，全球将有超过 1,200 万人受到心房颤动的影响。

根据英国心臟基金会的全球心臟和循环疾病情况说明书（2024 年），全球约有 2 亿人患有 CAD。血管补片在动脉修復、动脉内膜切除术和动脉瘤重建等手术中发挥重要作用，可改善治疗效果并最大限度地减少併发症，使其成为现代心血管治疗的重要组成部分。由于这些因素，市场正在扩大。

根据世界卫生组织2021年发布的数据，2015年至2050年间，60岁以上人口数量将翻一番，从12%增至22%，到2050年将达到21亿人。此外，到 2030 年，六分之一的人将年龄在 60 岁或以上。血液浓缩器市场预计将受到人口老化的推动，因为老年人患有心臟、肾臟和需要手术和液体管理的危重疾病的盛行率较高。

按产品类型划分，儿科血液浓缩器细分市场在 2023 年显示出巨大的收入占有率。该产品类别的快速增长是由于患有心臟病的儿科患者数量不断增加。

婴儿和新生儿的搭桥手术很复杂，因为儿科患者体型较小且体重较轻。儿科血液浓缩器可减少发炎细胞因子，纠正电解质和酸碱失衡，限制术后早期红血球输注，减少心臟肿胀，并改善儿科心臟手术的结果有助于促进手术切口的闭合。

本报告提供全球血液浓缩器的市场调查，彙整市场概要，市场影响因素及市场机会分析，法律制度，市场规模的转变·预测，各种区分·地区/各主要国家的详细分析，竞争情形，主要企业简介等资讯。

目录

第1章 血液浓缩器市场报告:简介

  • 调查范围
  • 市场分类
  • 市场估计

第2章 血液浓缩器市场:摘要整理

  • 市场概要

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 血液浓缩器市场:主要要素分析

  • 推动市场要素
    • 心血管疾病的盛行率和负担不断增加
    • 世界各地人口老化的负担
    • 各国政府的努力
  • 市场限制与课题
    • 缺乏熟练的专业人员
    • 手术期间的併发症
  • 市场机会
    • 意识的提升为新兴国家带来了成长机会
    • 对血液浓缩器的开发需求不断增加

第6章 血液浓缩器市场:波特的五力分析

第7章 血液浓缩器市场评估

  • 各产品类型
    • 儿童用血液浓缩器
    • 成人用血液浓缩器
  • 各终端用户
    • 医院
    • 门诊病人手术中心
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 血液浓缩器市场:企业·产品简介

  • Getinge AB
  • LivaNova PLC
  • Braile Biomedica
  • Terumo Corporation
  • MEDICA S.P.A.
  • Andocor
  • NIPRO CORPORATION
  • STERIS
  • Chalice Medical Ltd

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明·联络方式

Product Code: DIMDCL0501

Hemoconcentrators Market by Product Type (Pediatric Hemoconcentrators and Adult Hemoconcentrators), End-User (Hospitals and Ambulatory Surgical Centres), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increase in the prevalence and burden of cardiovascular diseases and escalating burden of the geriatric population globally

The hemoconcentrators market was valued at USD 11.63 million in 2023, growing at a CAGR of 3.24% during the forecast period from 2024 to 2030 to reach USD 14.04 million by 2030. The hemoconcentrators market is slated to witness growth owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, coronary artery disease (CAD), rising geriatric population, increasing number of government initiatives by countries, growing focus on improving the safety, affordability, and usability of hemoconcentrators among others that are expected to drive the market for hemoconcentrators during the forecast period from 2024 to 2030.

Hemoconcentrators Market Dynamics:

As per data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to recent data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are living with CAD around the world. Vascular patches are vital role in procedures like arterial repairs, endarterectomy, and aneurysm reconstruction, offering improved outcomes and minimizing complications, making them indispensable in contemporary cardiovascular treatments. Hence the market for same is increasing.

The rising prevalence of cardiovascular diseases and associated surgical interventions, such as arterial repairs and aneurysm reconstructions, is driving demand for advanced fluid management solutions. Hemoconcentrators are increasingly essential in maintaining fluid balance during these procedures, improving outcomes and reducing complications, thereby boosting their market growth.

As per data provided by the WHO 2021, between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. The aging population is driving the market for hemoconcentrators as older individuals face a higher prevalence of cardiac, renal, and critical conditions requiring surgeries and fluid management, where these devices are essential.

Therefore, the factors stated above collectively will drive the overall hemoconcentrators market during the forecast period from 2024 to 2030.

However, the dearth of skilled professionals, complications during surgery and others may limit their end-user base, thus acting as key constraints limiting the growth of the hemoconcentrators.

Hemoconcentrators Market Segment Analysis:

Hemoconcentrators Market by Product Type (Pediatric Hemoconcentrators and Adult Hemoconcentrators), End-User (Hospitals and Ambulatory Surgical Centres), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of hemoconcentrators, the pediatric hemoconcentrators category is expected to have a significant revenue share in the year 2023. The rapid growth of this product category is due to the increasing number of pediatric patients with heart diseases is the main reason responsible for the growth of pediatric hemoconcentrators.

According to NHS 2021, one in a hundred babies are born with congenital heart disease in the UK.

As per the Centers for Disease Control and Prevention, 2022, about 1 in 4 babies born with a heart defect have a critical congenital heart defect (CHD).

The increasing importance of pediatric coronary artery bypass surgery (PCABS) for congenital heart disease in infants and children undergoing modern cardiac surgical procedures, because of its life-saving potential in unsuccessful coronary transfer operations is going to increase the demand for pediatric hemoconcentrators.

Due to the small size and low weight of pediatric patients among other factors, performing bypass surgery in infants and neonates is complicated. Pediatric hemoconcentrators help in reducing inflammatory cytokines and correcting electrolyte and acid-base imbalances, limit early postoperative RBCs transfusions, reduces swelling of the heart, and facilitate the closing of surgical incision for better outcome of pediatric cardiac surgery.

For example, CAPIOX(R) HC05 hemoconcentrators by Terumo Corporation is a type of pediatric Hemoconcentrator that efficiently concentrates blood using a polysulfone membrane material at a high ultrafiltration rate.

Therefore, owing to the above-mentioned factors the pediatric hemoconcentrators category is expected to witness substantial growth in the overall hemoconcentrators market during the given forecast period from 2024 to 2030.

North America is expected to dominate the overall hemoconcentrators market:

Among all the regions, North America is expected to dominate the hemoconcentrators market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. The increasing prevalence of cardiovascular conditions such as coronary artery disease (CAD), myocardial infarction, and peripheral artery disease (PAD), along with rising comorbidities like hypertension & hyperlipidemia, growing government initiatives in the cardiovascular sector in the US, and presence of key players in the region is expected to drive the continued expansion and innovation in the market for hemoconcentrators during the forecast period from 2024 to 2030.

As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (2024), it was stated that 805,000 people in the US have a myocardial infarction every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure, among others. Some of the key risk factors associated with heart disease are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of the Americans (47%) have at least one of these three risk factors.

According to data from the Canadian Institute for Health Information (2024), it stated that in 2022, 2.4 million Canadians were affected by heart disease.

Since cardiovascular disorders are rising in the region among middle-aged individuals, the demand for more treatment options is increasing significantly. This trend is fueling investment in innovative technologies and expanding the market for hemoconcentrators.

Also, the presence of key market players in the region is significantly bolstering the market for hemoconcentrators. Major companies have established strong footholds in the region, driving innovation and market growth. The extensive research and development activities, combined with a robust distribution network, enable these players to deliver high-quality, technologically advanced products to a wide end-user base.

Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North America region in the hemoconcentrators market.

Hemoconcentrators Market key players:

Some of the key market players operating in the hemoconcentrators market include Getinge AB, LivaNova PLC, Braile Biomedica, Terumo Corporation, MEDICA S.P.A., Andocor, NIPRO CORPORATION, STERIS, Chalice Medical Ltd, and others.

Recent Developmental Activities in the Hemoconcentrators Market:

  • In June 2021, STERIS completed the acquisition of Cantel Medical which was the parent company of Medivators Inc. and Minntech, leading manufacturers of hemoconcentrators.

Key Takeaways from the Hemoconcentrators Market Report Study

  • Market size analysis for current hemoconcentrators market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the hemoconcentrators market
  • Various opportunities available for the other competitors in the hemoconcentrators market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current hemoconcentrators market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for hemoconcentrators market growth in the coming future?

Target audience who can be benefited from this Hemoconcentrators Market Report Study

  • Hemoconcentrators product providers
  • Research organizations and consulting companies
  • Hemoconcentrators-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in hemoconcentrators
  • Various end-users who want to know more about the hemoconcentrators market and the latest developments in the hemoconcentrators market

Frequently Asked Questions for the Hemoconcentrators Market:

1. What are hemoconcentrators?

  • The hemoconcentrator is an ultrafiltration device consisting of semipermeable membrane fibers that remove plasma water and solutes. Blood passes through fibers of a microporous membrane, and since the hydrostatic pressure inside the fibers is higher than outside, effluent fluid can pass through the membrane and be drained.

2. What is the market for hemoconcentrators?

  • The hemoconcentrators market was valued at USD 11.63 million in 2023, growing at a CAGR of 3.24% during the forecast period from 2024 to 2030 to reach USD 14.04 million by 2030.

3. What are the drivers for the hemoconcentrators market?

  • The hemoconcentrators market is slated to witness growth owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, coronary artery disease (CAD), rising geriatric population, increasing number of government initiatives by countries, growing focus on improving the safety, affordability, and usability of hemoconcentrators among others that are expected to drive the market for hemoconcentrators during the forecast period from 2024 to 2030.

4. Who are the key players operating in the hemoconcentrators market?

  • Some of the key market players operating in the hemoconcentrators market include Getinge AB, LivaNova PLC, Braile Biomedica, Terumo Corporation, MEDICA S.P.A., Andocor, NIPRO CORPORATION, STERIS, Chalice Medical Ltd, and others.

5. Which region has the highest share in the hemoconcentrators market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the hemoconcentrators market. The increasing prevalence of cardiovascular conditions such as coronary artery disease (CAD), myocardial infarction, and peripheral artery disease (PAD), along with rising comorbidities like hypertension & hyperlipidemia, growing government initiatives in the cardiovascular sector in the US, and presence of key players in the region is expected to drive the continued expansion and innovation in the market for hemoconcentrators during the forecast period from 2024 to 2030.

Table of Contents

1. Hemoconcentrators Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Hemoconcentrators Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Hemoconcentrators Market Key Factors Analysis

  • 5.1. Hemoconcentrators Market Drivers
    • 5.1.1. Increase in the prevalence and burden of cardiovascular diseases
    • 5.1.2. The escalating burden of the geriatric population globally
    • 5.1.3. Government initiatives by the countries
  • 5.2. Hemoconcentrators Market Restraints and Challenges
    • 5.2.1. The dearth of skilled professionals
    • 5.2.2. Complications during surgery
  • 5.3. Hemoconcentrators Market Opportunities
    • 5.3.1. Growth opportunities in emerging countries owing to rising awareness
    • 5.3.2. Rising need to develop hemoconcentrators

6. Hemoconcentrators Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Hemoconcentrators Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Pediatric Hemoconcentrators
    • 7.1.2. Adult Hemoconcentrators
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centres
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Hemoconcentrators Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Hemoconcentrators Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.3.3. India Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Hemoconcentrators Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Hemoconcentrators Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Hemoconcentrators Market Size in USD million (2021-2030)

8. Hemoconcentrators Market Company and Product Profiles

  • 8.1. Getinge AB
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. LivaNova PLC
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Braile Biomedica
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Terumo Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. MEDICA S.P.A.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Andocor
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. NIPRO CORPORATION
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. STERIS
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Chalice Medical Ltd
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Hemoconcentrators Market in Global (2021-2030)
  • Table 3: Hemoconcentrators Market in Global by Product Type (2021-2030)
  • Table 4: Hemoconcentrators Market in Global by End-User (2021-2030)
  • Table 5: Hemoconcentrators Market in Global by Geography (2021-2030)
  • Table 6: Hemoconcentrators Market in North America (2021-2030)
  • Table 7: Hemoconcentrators Market in the United States (2021-2030)
  • Table 8: Hemoconcentrators Market in Canada (2021-2030)
  • Table 9: Hemoconcentrators Market in Mexico (2021-2030)
  • Table 10: Hemoconcentrators Market in Europe (2021-2030)
  • Table 11: Hemoconcentrators Market in France (2021-2030)
  • Table 12: Hemoconcentrators Market in Germany (2021-2030)
  • Table 13: Hemoconcentrators Market in United Kingdom (2021-2030)
  • Table 14: Hemoconcentrators Market in Italy (2021-2030)
  • Table 15: Hemoconcentrators Market in Spain (2021-2030)
  • Table 16: Hemoconcentrators Market in the Rest of Europe (2021-2030)
  • Table 17: Hemoconcentrators Market in Asia-Pacific (2021-2030)
  • Table 18: Hemoconcentrators Market in China (2021-2030)
  • Table 19: Hemoconcentrators Market in Japan (2021-2030)
  • Table 20: Hemoconcentrators Market in India (2021-2030)
  • Table 21: Hemoconcentrators Market in Australia (2021-2030)
  • Table 22: Hemoconcentrators Market in South Korea (2021-2030)
  • Table 23: Hemoconcentrators Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Hemoconcentrators Market in the Rest of the World (2021-2030)
  • Table 25: Hemoconcentrators Market in the Middle East (2021-2030)
  • Table 26: Hemoconcentrators Market in Africa (2021-2030)
  • Table 27: Hemoconcentrators Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Hemoconcentrators Market in Global (2021-2030)
  • Figure 3: Hemoconcentrators Market in Global by Product Type (2021-2030)
  • Figure 4: Hemoconcentrators Market in Global by End-User (2021-2030)
  • Figure 5: Hemoconcentrators Market in Global by Geography (2021-2030)
  • Figure 6: Hemoconcentrators Market in North America (2021-2030)
  • Figure 7: Hemoconcentrators Market in the United States (2021-2030)
  • Figure 8: Hemoconcentrators Market in Canada (2021-2030)
  • Figure 9: Hemoconcentrators Market in Mexico (2021-2030)
  • Figure 10: Hemoconcentrators Market in Europe (2021-2030)
  • Figure 11: Hemoconcentrators Market in France (2021-2030)
  • Figure 12: Hemoconcentrators Market in Germany (2021-2030)
  • Figure 13: Hemoconcentrators Market in United Kingdom (2021-2030)
  • Figure 14: Hemoconcentrators Market in Italy (2021-2030)
  • Figure 15: Hemoconcentrators Market in Spain (2021-2030)
  • Figure 16: Hemoconcentrators Market in the Rest of Europe (2021-2030)
  • Figure 17: Hemoconcentrators Market in Asia-Pacific (2021-2030)
  • Figure 18: Hemoconcentrators Market in China (2021-2030)
  • Figure 19: Hemoconcentrators Market in Japan (2021-2030)
  • Figure 20: Hemoconcentrators Market in India (2021-2030)
  • Figure 21: Hemoconcentrators Market in Australia (2021-2030)
  • Figure 22: Hemoconcentrators Market in South Korea (2021-2030)
  • Figure 23: Hemoconcentrators Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Hemoconcentrators Market in the Rest of the World (2021-2030)
  • Figure 25: Hemoconcentrators Market in the Middle East (2021-2030)
  • Figure 26: Hemoconcentrators Market in Africa (2021-2030)
  • Figure 27: Hemoconcentrators Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis